The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
778
November 4, 1988
View Complete Issue         Table of Contents 2019 
Clomipramine for Obsessive Compulsive Disorder
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Clomipramine for Obsessive Compulsive Disorder
November 4, 1988 (Issue: 778)
Clomipramine (Anafranil - Ciba-Geigy), a tricyclic antidepressant, is now available for treatment of obsessive compulsive disorder (OCD) in accordance with the new US Food and Drug Administration (FDA) procedure for promising investigational drugs...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Clomipramine for Obsessive Compulsive Disorder
Article code: 778b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.